Schuessler Institute for Social Research, Indiana University, 1022 East Third St., Bloomington, IN 47405, USA.
Am J Psychiatry. 2010 Nov;167(11):1321-30. doi: 10.1176/appi.ajp.2010.09121743. Epub 2010 Sep 15.
Clinicians, advocates, and policy makers have presented mental illnesses as medical diseases in efforts to overcome low service use, poor adherence rates, and stigma. The authors examined the impact of this approach with a 10-year comparison of public endorsement of treatment and prejudice.
The authors analyzed responses to vignettes in the mental health modules of the 1996 and 2006 General Social Survey describing individuals meeting DSM-IV criteria for schizophrenia, major depression, and alcohol dependence to explore whether more of the public 1) embraces neurobiological understandings of mental illness; 2) endorses treatment from providers, including psychiatrists; and 3) reports community acceptance or rejection of people with these disorders. Multivariate analyses examined whether acceptance of neurobiological causes increased treatment support and lessened stigma.
In 2006, 67% of the public attributed major depression to neurobiological causes, compared with 54% in 1996. High proportions of respondents endorsed treatment, with general increases in the proportion endorsing treatment from doctors and specific increases in the proportions endorsing psychiatrists for treatment of alcohol dependence (from 61% in 1996 to 79% in 2006) and major depression (from 75% in 1996 to 85% in 2006). Social distance and perceived danger associated with people with these disorders did not decrease significantly. Holding a neurobiological conception of these disorders increased the likelihood of support for treatment but was generally unrelated to stigma. Where associated, the effect was to increase, not decrease, community rejection.
More of the public embraces a neurobiological understanding of mental illness. This view translates into support for services but not into a decrease in stigma. Reconfiguring stigma reduction strategies may require providers and advocates to shift to an emphasis on competence and inclusion.
临床医生、倡导者和政策制定者将精神疾病视为医学疾病,以努力克服服务利用率低、依从性差和污名化问题。作者通过对 10 年来公众对治疗的支持和偏见的比较,研究了这种方法的影响。
作者分析了 1996 年和 2006 年一般社会调查精神健康模块中描述符合 DSM-IV 精神分裂症、重度抑郁症和酒精依赖标准的个体的个案研究,以探讨公众是否有更多的人:1)接受精神疾病的神经生物学理解;2)支持提供者的治疗,包括精神科医生;3)报告社区对这些障碍患者的接受或拒绝。多变量分析检验了对神经生物学病因的接受是否会增加对治疗的支持,减少污名化。
2006 年,67%的公众将重度抑郁症归因于神经生物学原因,而 1996 年为 54%。有相当大比例的受访者支持治疗,总体上增加了医生治疗的比例,具体增加了治疗酒精依赖(从 1996 年的 61%增加到 2006 年的 79%)和重度抑郁症(从 1996 年的 75%增加到 2006 年的 85%)的精神科医生治疗的比例。与这些障碍相关的社会距离和感知危险没有显著下降。持有这些障碍的神经生物学概念增加了对治疗的支持的可能性,但通常与耻辱感无关。如果相关,其效果是增加而不是减少社区排斥。
更多的公众接受精神疾病的神经生物学理解。这种观点转化为对服务的支持,但不会减少耻辱感。重新配置减少耻辱感的策略可能需要提供者和倡导者将重点转移到能力和包容上。